Epigenetic mechanisms in breast cancer therapy and resistance

L Garcia-Martinez, Y Zhang, Y Nakata, HL Chan… - Nature …, 2021 - nature.com
The majority of breast cancers express the estrogen receptor (ERα) and agents targeting this
pathway represent the main treatment modality. Endocrine therapy has proven successful in …

[HTML][HTML] Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options

JY So, J Ohm, S Lipkowitz, L Yang - Pharmacology & therapeutics, 2022 - Elsevier
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by extensive
intra-tumoral heterogeneity, and frequently develops resistance to therapies. Tumor …

Methionine metabolism in health and cancer: a nexus of diet and precision medicine

SM Sanderson, X Gao, Z Dai, JW Locasale - Nature Reviews Cancer, 2019 - nature.com
Methionine uptake and metabolism is involved in a host of cellular functions including
methylation reactions, redox maintenance, polyamine synthesis and coupling to folate …

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

L Mosca, A Ilari, F Fazi, YG Assaraf, G Colotti - Drug Resistance Updates, 2021 - Elsevier
Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …

H3K27me3 conditions chemotolerance in triple-negative breast cancer

J Marsolier, P Prompsy, A Durand, AM Lyne… - Nature …, 2022 - nature.com
The persistence of cancer cells resistant to therapy remains a major clinical challenge. In
triple-negative breast cancer, resistance to chemotherapy results in the highest recurrence …

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases

Y Wang, J Hu, S Wu, JS Fleishman, Y Li, Y Xu… - … and Targeted Therapy, 2023 - nature.com
Ferroptosis, a unique modality of cell death with mechanistic and morphological differences
from other cell death modes, plays a pivotal role in regulating tumorigenesis and offers a …

Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis

R Chen, CA Ishak, DD De Carvalho - Cancer discovery, 2021 - AACR
Features of the cancer epigenome distinguish cancers from their respective cell of origin and
establish therapeutic vulnerabilities that can be exploited through pharmacologic inhibition …

The interplay between DNA and histone methylation: molecular mechanisms and disease implications

Y Li, X Chen, C Lu - EMBO reports, 2021 - embopress.org
Methylation of cytosine in CpG dinucleotides and histone lysine and arginine residues is a
chromatin modification that critically contributes to the regulation of genome integrity …

PRMT inhibition induces a viral mimicry response in triple-negative breast cancer

Q Wu, DY Nie, W Ba-Alawi, YS Ji, ZW Zhang… - Nature chemical …, 2022 - nature.com
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype with the
worst prognosis and few effective therapies. Here we identified MS023, an inhibitor of type I …

[HTML][HTML] Single cell cancer epigenetics

M Casado-Pelaez, A Bueno-Costa, M Esteller - Trends in Cancer, 2022 - cell.com
Bulk sequencing methodologies have allowed us to make great progress in cancer
research. Unfortunately, these techniques lack the resolution to fully unravel the epigenetic …